Cas:279261-83-5 4-(4-bromo-3-fluorophenyl)morpholine manufacturer & supplier

Chemical Name:4-(4-bromo-3-fluorophenyl)morpholine

CAS.NO:279261-83-5

Synonyms:4-(4-bromo-3-fluorophenyl)morpholine

Molecular Formula:C₁₀H₁₁BrFNO

Molecular Weight:260.10300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:12.47000

Exact Mass:259.00100

LogP:2.48980

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(4-bromo-3-fluorophenyl)morpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-bromo-3-fluorophenyl)morpholine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(4-bromo-3-fluorophenyl)morpholine Use and application,4-(4-bromo-3-fluorophenyl)morpholine technical grade,usp/ep/jp grade.

Related News: He said it is “normal” for scientists and clinicians to discuss and debate data from experiments and clinical trials, but added those discussions have taken a turn “outside the boundaries of legitimate scientific deliberation.” arachno hexaborane(12) manufacturers He said it is “normal” for scientists and clinicians to discuss and debate data from experiments and clinical trials, but added those discussions have taken a turn “outside the boundaries of legitimate scientific deliberation.” 1,4-Dimethoxy-2-(1,2-epoxyethyl)-5-propylbenzol suppliers According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. buta-1,3-dienyl-phosphonic acid diisopropyl ester vendor & factory The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. ,In 2018, the Bengaluru-based Natural Capsules set up an R&D centre in at Attibele, Bengaluru. In 2020, when PLI scheme was announced it applied for the same.